285 related articles for article (PubMed ID: 22647364)
21. Circulating microRNAs: possible prediction biomarkers for personalized therapy of non-small-cell lung carcinoma.
Gao W; Liu L; Lu X; Shu Y
Clin Lung Cancer; 2011 Jan; 12(1):14-7. PubMed ID: 21273174
[No Abstract] [Full Text] [Related]
22. MicroRNA classifiers for predicting prognosis of squamous cell lung cancer.
Raponi M; Dossey L; Jatkoe T; Wu X; Chen G; Fan H; Beer DG
Cancer Res; 2009 Jul; 69(14):5776-83. PubMed ID: 19584273
[TBL] [Abstract][Full Text] [Related]
23. MicroRNAs: potential biomarkers for cancer diagnosis, prognosis and targets for therapy.
Cho WC
Int J Biochem Cell Biol; 2010 Aug; 42(8):1273-81. PubMed ID: 20026422
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of microRNA expression profiles that may predict recurrence of localized stage I non-small cell lung cancer after surgical resection.
Patnaik SK; Kannisto E; Knudsen S; Yendamuri S
Cancer Res; 2010 Jan; 70(1):36-45. PubMed ID: 20028859
[TBL] [Abstract][Full Text] [Related]
25. MicroRNAs and cancer--new paradigms in molecular oncology.
Negrini M; Nicoloso MS; Calin GA
Curr Opin Cell Biol; 2009 Jun; 21(3):470-9. PubMed ID: 19411171
[TBL] [Abstract][Full Text] [Related]
26. MicroRNAs in an oral cancer context - from basic biology to clinical utility.
Gorenchtein M; Poh CF; Saini R; Garnis C
J Dent Res; 2012 May; 91(5):440-6. PubMed ID: 22166582
[TBL] [Abstract][Full Text] [Related]
27. Prognosis of non-small cell lung cancer patients by detecting circulating cancer cells in the peripheral blood with multiple marker genes.
Sher YP; Shih JY; Yang PC; Roffler SR; Chu YW; Wu CW; Yu CL; Peck K
Clin Cancer Res; 2005 Jan; 11(1):173-9. PubMed ID: 15671543
[TBL] [Abstract][Full Text] [Related]
28. MicroRNAs: a new key in lung cancer.
Zhang Y; Yang Q; Wang S
Cancer Chemother Pharmacol; 2014 Dec; 74(6):1105-11. PubMed ID: 25135624
[TBL] [Abstract][Full Text] [Related]
29. MicroRNAs in clinical oncology: at the crossroads between promises and problems.
Metias SM; Lianidou E; Yousef GM
J Clin Pathol; 2009 Sep; 62(9):771-6. PubMed ID: 19734473
[TBL] [Abstract][Full Text] [Related]
30. Prognostic, therapeutic and diagnostic potential of microRNAs in non-small cell lung cancer.
Markou A; Liang Y; Lianidou E
Clin Chem Lab Med; 2011 Oct; 49(10):1591-603. PubMed ID: 21767219
[TBL] [Abstract][Full Text] [Related]
31. Isothermally sensitive detection of serum circulating miRNAs for lung cancer diagnosis.
Li Y; Liang L; Zhang CY
Anal Chem; 2013 Dec; 85(23):11174-9. PubMed ID: 24215456
[TBL] [Abstract][Full Text] [Related]
32. MicroRNA signature predicts survival and relapse in lung cancer.
Yu SL; Chen HY; Chang GC; Chen CY; Chen HW; Singh S; Cheng CL; Yu CJ; Lee YC; Chen HS; Su TJ; Chiang CC; Li HN; Hong QS; Su HY; Chen CC; Chen WJ; Liu CC; Chan WK; Chen WJ; Li KC; Chen JJ; Yang PC
Cancer Cell; 2008 Jan; 13(1):48-57. PubMed ID: 18167339
[TBL] [Abstract][Full Text] [Related]
33. MicroRNAs in human lung cancer.
Kang SM; Lee HJ
Exp Biol Med (Maywood); 2014 Nov; 239(11):1505-13. PubMed ID: 24872439
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA as a new factor in lung and esophageal cancer.
Billeter AT; Barnett RE; Druen D; Polk HC; van Berkel VH
Semin Thorac Cardiovasc Surg; 2012; 24(3):155-65. PubMed ID: 23200070
[TBL] [Abstract][Full Text] [Related]
35. Prognostic significance of serum miRNA-21 expression in human non-small cell lung cancer.
Wang ZX; Bian HB; Wang JR; Cheng ZX; Wang KM; De W
J Surg Oncol; 2011 Dec; 104(7):847-51. PubMed ID: 21721011
[TBL] [Abstract][Full Text] [Related]
36. miRNAs as molecular biomarkers of cancer.
Fabbri M
Expert Rev Mol Diagn; 2010 May; 10(4):435-44. PubMed ID: 20465498
[TBL] [Abstract][Full Text] [Related]
37. Accurate classification of non-small cell lung carcinoma using a novel microRNA-based approach.
Bishop JA; Benjamin H; Cholakh H; Chajut A; Clark DP; Westra WH
Clin Cancer Res; 2010 Jan; 16(2):610-9. PubMed ID: 20068099
[TBL] [Abstract][Full Text] [Related]
38. Non-small-cell lung cancer and miRNAs: novel biomarkers and promising tools for treatment.
Feng B; Zhang K; Wang R; Chen L
Clin Sci (Lond); 2015 May; 128(10):619-34. PubMed ID: 25760961
[TBL] [Abstract][Full Text] [Related]
39. Restoration of tumour suppressor hsa-miR-145 inhibits cancer cell growth in lung adenocarcinoma patients with epidermal growth factor receptor mutation.
Cho WC; Chow AS; Au JS
Eur J Cancer; 2009 Aug; 45(12):2197-206. PubMed ID: 19493678
[TBL] [Abstract][Full Text] [Related]
40. Circulating MicroRNA Signatures of Tumor-Derived Exosomes for Early Diagnosis of Non-Small-Cell Lung Cancer.
Rosell R; Wei J; Taron M
Clin Lung Cancer; 2009 Jan; 10(1):8-9. PubMed ID: 19289365
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
